Regulatory Compliance

CAMINUS to Manufacture Amprius Silicon-Anode Cells in Indianapolis

Indianapolis – October 05, 2026 -- CAMINUS, formerly EnPower, has signed a contract manufacturing agreement with Amprius Technologies (NYSE: AMPX) to produce Amprius-designed silicon-anode pouch cells at its Indianapolis facility, adding domestic capacity for the aviation, defense, and uncrewed systems markets. Qualification builds are already underway, with volume production scheduled for the first quarter of 2027.

Agreement covers full production chain from partial assembly to finished cells

The deal spans the entire cell production process, from partial assembly of Amprius-supplied components to full cell manufacturing. This staged structure allows different cell formats to be produced according to their volume needs and qualification status, supporting Amprius's contract manufacturing strategy of expanding capacity with minimal capital investment.

Pryzm Rebrands to Belisar After 6X Revenue Growth in Defense Tech

Boston – October 05, 2026 -- Pryzm, the CRM built for government contracting, has rebranded as Belisar following 6X annual recurring revenue growth and adoption by a third of the more than 60 defense tech unicorns currently operating.

Defense budget request hits $1.5 trillion as venture capital floods the sector

The White House has requested $1.5 trillion for national defense in FY27, the largest defense budget request in U.S. history. Venture investment in defense tech reached $49.1 billion in 2025, nearly double the prior year, yet contractors still face slow, opaque paths from idea to deployed contract.

Talkiatry Earns Joint Commission Gold Seal for Behavioral Health

New York – October 05, 2026 -- Talkiatry, the largest psychiatric provider group in the U.S., has received The Joint Commission's Gold Seal of Approval® for Behavioral Health, covering care delivered to more than 170 million lives nationwide.

Accreditation follows four million patient visits and rapid national expansion

The accreditation arrives shortly after Talkiatry surpassed four million patient visits and serves as the preferred in-network psychiatry partner for more than 70 U.S. health systems. To earn the designation, the company underwent a comprehensive review of its operations, patient care delivery, and privacy and security practices, followed by on-site surveyor observations and interviews.

Arevon Energy Tops GRESB Solar Ranking in Americas, Scores 98.2

Scottsdale, Ariz. – October 05, 2026 -- Arevon Energy, Inc. earned the No. 1 ranking in the Americas for Renewable Power: Solar Power Generation in the 2026 GRESB ESG Benchmark Assessment, marking its second consecutive year atop the category with an overall score of 98.2 out of 100.

Arevon posts a perfect Performance Score of 60 out of 60

The GRESB assessment awarded Arevon a five-star rating alongside the perfect Performance Score, reflecting results across the benchmark's sustainability indicators. The company has participated in the annual GRESB Assessment for nine consecutive years, using it to track ESG management progress and set priorities.

SignSplit Raises $400M Seed Round at $1B Valuation With W Group

Wilmington – October 05, 2026 -- SignSplit PBC has secured a $400 million strategic seed round from W Group that values the data-licensing startup at $1 billion, as it emerges from stealth to build infrastructure for compensating people and institutions for their data, work and likeness.

W Group's fintech ecosystem backs SignSplit's data-licensing model

The financing comes from W Group, a global fintech and technology ecosystem serving more than 40 million users across 150 countries. The deal combines capital with a multi-year package of strategic resources to support SignSplit's global rollout.

HanchorBio Wins FDA IND Clearance for Trispecific Drug HCB303

Taipei, Shanghai and San Francisco – October 05, 2026 -- HanchorBio, Inc. (TWSE: 7827) said the U.S. Food and Drug Administration has cleared the investigational new drug application for HCB303, clearing the path for the company's second trispecific immunotherapy to enter human testing.

FDA clearance unlocks Phase 1 trial for advanced solid tumors

The clearance allows HanchorBio to launch a Phase 1 first-in-human, dose-escalation, multi-regional study (HCB303-ONC-101) in patients with advanced, relapsed or refractory solid tumors who have exhausted standard treatment options. The trial will assess safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, biomarkers and preliminary antitumor activity. The decision follows pre-IND feedback HanchorBio received from the FDA in August 2026.

Solidion Holds Firm on Flux Power Bid After Board Rejection

Dallas – October 05, 2026 -- Solidion Technology, Inc. (NASDAQ: STI) has refused to raise its acquisition offer for Flux Power Holdings, Inc. (NASDAQ: FLUX), calling the bid "best and final" after Flux's board rejected the proposal as undervaluing the company.

Solidion rejects board's undervaluation claim

Jaymes Winters, Chairman and CEO of Solidion Technology, said the company strongly disagrees with Flux Power's assertion that the offer undervalues the battery maker, stating the bid already reflects the capital and execution needed to stabilize the business. Winters added that Solidion has no intention of increasing the offer and will continue pursuing other acquisition targets in parallel.

Paul Christiano Named 2026 Hinton Lectures Speaker in Toronto

Toronto – October 05, 2026 -- The Hinton Lectures, co-founded by Nobel laureate Geoffrey Hinton, will return to Toronto for a third year on November 9-11, 2026, naming Paul Christiano as this year's distinguished lecturer.

Christiano brings OpenAI and alignment credentials to the stage

Christiano was an early researcher at OpenAI, where he developed reinforcement learning from human feedback, a technique now foundational to large language model training. He currently serves as founder and executive director of the Alignment Research Center, a non-profit focused on understanding decision-making inside machine learning systems. He also holds roles as Senior Technical Advisor at NIST's Center for AI Standards and Innovation, Board Member of the OpenAI Foundation, and Member of the OpenAI Safety and Security Committee.

EU Commission Reiterates Concerns Over UPM-Sappi Paper JV

Helsinki – October 05, 2026 -- UPM-Kymmene Corporation and Sappi have received a Letter of Facts from the European Commission restating serious concerns about their proposed graphic paper Joint Venture, the companies disclosed as inside information on October 5, 2026.

Commission maintains objections despite ongoing talks

UPM and Sappi are analyzing the Letter of Facts and preparing a formal response. UPM said it disagrees with the Commission's preliminary assessment and will continue engaging with the review process, while planning to submit remedy proposals that fall short of divestments, citing the transaction's underlying rationale.

Basware Completes Acquisition of Fraud Prevention Firm Trustpair

Paris – October 05, 2026 -- Basware, the global leader in Invoice Lifecycle Management, has completed its acquisition of payment fraud prevention platform Trustpair, finalizing a deal first announced in August 2026.

Basware extends invoice oversight to the point of payment

The acquisition closes a gap in enterprise finance controls: an invoice can be authentic, accurate and fully approved, yet still result in a fraudulent payment if the associated supplier bank account is compromised. Basware's platform validates that an invoice obligation is legitimate and compliant; Trustpair now adds verification that the supplier is genuine, the bank account matches that supplier, and funds reach the intended destination.